Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Sebastian Havervall, Ulrika Marking, Max Gordon, Henry Ng, Nina Greilert-Norin, Sarah Lindbo, Kim Blom, Peter Nilsson, Mia Phillipson, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Sophia Hober, Charlotte Thålin
doi: https://doi.org/10.1101/2021.08.12.21261951
Sebastian Havervall
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Ulrika Marking
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Max Gordon
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Henry Ng
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
2Department of Medical Cell Biology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Nina Greilert-Norin
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Sarah Lindbo
3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Kim Blom
4Public Health Agency of Sweden, Solna, Sweden
Peter Nilsson
3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Mia Phillipson
2Department of Medical Cell Biology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Jonas Klingström
4Public Health Agency of Sweden, Solna, Sweden
5Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Sara Mangsbo
6Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Mikael Åberg
7Department of Medical Sciences, Clinical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Sophia Hober
3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Charlotte Thålin
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden

Data Availability
The anonymized datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Posted August 12, 2021.
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Sebastian Havervall, Ulrika Marking, Max Gordon, Henry Ng, Nina Greilert-Norin, Sarah Lindbo, Kim Blom, Peter Nilsson, Mia Phillipson, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Sophia Hober, Charlotte Thålin
medRxiv 2021.08.12.21261951; doi: https://doi.org/10.1101/2021.08.12.21261951
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Sebastian Havervall, Ulrika Marking, Max Gordon, Henry Ng, Nina Greilert-Norin, Sarah Lindbo, Kim Blom, Peter Nilsson, Mia Phillipson, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Sophia Hober, Charlotte Thålin
medRxiv 2021.08.12.21261951; doi: https://doi.org/10.1101/2021.08.12.21261951
Subject Area
Subject Areas
- Addiction Medicine (228)
- Allergy and Immunology (506)
- Anesthesia (110)
- Cardiovascular Medicine (1244)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10027)
- Gastroenterology (500)
- Genetic and Genomic Medicine (2462)
- Geriatric Medicine (238)
- Health Economics (479)
- Health Informatics (1645)
- Health Policy (753)
- Hematology (250)
- HIV/AIDS (535)
- Medical Education (253)
- Medical Ethics (75)
- Nephrology (268)
- Neurology (2289)
- Nursing (139)
- Nutrition (352)
- Oncology (1248)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (325)
- Pediatrics (733)
- Primary Care Research (282)
- Public and Global Health (4840)
- Radiology and Imaging (838)
- Respiratory Medicine (651)
- Rheumatology (286)
- Sports Medicine (227)
- Surgery (268)
- Toxicology (44)
- Transplantation (125)
- Urology (99)